|
1.
|
Cooper K, Squires H, Carrol C, Papaioannou
D, Booth A, Logan RF, Maguire C, Hind D and Tappenden P:
Chemoprevention of colorectal cancer: systematic review and
economic evaluation. Health Technol Assess. 14:1–206. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar
|
|
3.
|
National Cancer Information Center: Cancer
incidence. Goyang. http://www.cancer.go.kr/ncic/cics.
Accessed Dec 29, 2011.
|
|
4.
|
Kelly C and Cassidy J: Chemotherapy in
metastatic colorectal cancer. Surg Oncol. 16:65–70. 2007.
View Article : Google Scholar
|
|
5.
|
Yang SY, Sales KM, Fuller BF, Seifalian AM
and Winslet MC: Apoptosis and colorectal cancer: implications for
therapy. Trends Mol Med. 15:225–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Peter ME: The flip side of FLIP. Biochem
J. 382:E1–E3. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Ashkenazi A: Targeting the extrinsic
apoptosis pathway in cancer. Cytokine Growth Factor Rev.
19:325–331. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Inada H, Izawa I, Nishizawa M, Fujita E,
Kiyono T, Takahashi T, Momoi T and Inagaki I: Keratin attenuates
tumor necrosis factor-induced cytotoxicity through association with
TRADD. J Cell Biol. 155:415–426. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Cory S and Adams JM: The Bcl2 family:
regulators of the cellular life-or-death switch. Nat Rev Cancer.
2:647–656. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Kuwana T, Mackey MR, Perkins G, Ellisman
MH, Latterich M, Schneiter R, Green DR and Newmeyer DD: Bid, Bax,
and lipids cooperate to form supramolecular openings in the outer
mitochondrial membrane. Cell. 111:331–342. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Oliver L and Vallette FM: The role of
caspases in cell death and differentiation. Drug Resist Updat.
8:163–170. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Iannolo G, Conticello C, Memeo L and De
Maria R: Apoptosis in normal and cancer stem cells. Crit Rev Oncol
Hematol. 66:42–51. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Kupchan SM, Streelman DR and Sneden AT:
Psorospermin, a new antileukemic xanthone from Psorospermum
febrifugum. J Nat Prod. 43:296–301. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Cassady JM, Baird WM and Chang CJ: Natural
products as a source of potential cancer chemotherapeutic and
chemo-preventive agents. J Nat Prod. 53:23–41. 1990.PubMed/NCBI
|
|
15.
|
Dorr RT, Liddil JD, Von Hoff DD, Soble M
and Osborne CK: Antitumor activity and murine pharmacokinetics of
parenteral acronycine. Cancer Res. 49:340–344. 1989.PubMed/NCBI
|
|
16.
|
Kang JA, Yang Z, Lee JY, De U, Kim TH,
Park JY, Lee HJ, Park YJ, Chu P, Kim KS, Jeong LS and Moon HR:
Design, synthesis and anticancer activity of novel
dihydrobenzofuro[4,5-b][1,8]naphthyridin-6-one derivatives. Bioorg
Med Chem Lett. 21:5730–5734. 2011.PubMed/NCBI
|
|
17.
|
Harris MH and Thompson CB: The role of the
Bcl-2 family in the regulation of outer mitochondrial membrane
permeability. Cell Death Differ. 7:1182–1191. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Call JA, Eckhardt SG and Camidge DR:
Targeted manipulation of apoptosis in cancer treatment. Lancet
Oncol. 9:1002–1011. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Lorenzo HK and Susin SA: Therapeutic
potential of AIF-mediated caspase-independent programmed cell
death. Drug Resist Updat. 10:235–255. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Antonsson B and Martinou JC: The Bcl-2
protein family. Exp Cell Res. 256:50–57. 2000. View Article : Google Scholar
|
|
21.
|
Guo B, Godzik A and Reed JC: Bcl-G, a
novel pro-apoptotic member of the Bcl-2 family. J Biol Chem.
276:2780–2785. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Molinari M: Cell cycle checkpoints and
their inactivation in human cancer. Cell Prolif. 33:261–274. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Sherr CJ: Cancer cell cycles. Science.
274:1672–1677. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Murray AW: Recycling the cell cycle:
cyclins revisited. Cell. 116:221–234. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Sancar A, Lindsey-Boltz LA, Unsal-Kaçmaz K
and Linn S: Molecular mechanisms of mammalian DNA repair and the
DNA damage checkpoints. Annu Rev Biochem. 73:39–85. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Taylor WR and Stark GR: Regulation of the
G2/M transition by p53. Oncogene. 20:1803–1815. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Le Gac G, Estève PO, Ferec C and Pradhan
S: DNA damage-induced down-regulation of human Cdc25C and Cdc2 is
mediated by cooperation between p53 and maintenance DNA
(cytosine-5) methyltransferase 1. J Biol Chem. 281:24161–24170.
2006.PubMed/NCBI
|
|
28.
|
Malumbres M and Barbacid M: Cell cycle,
CDKs and cancer: a changing paradigm. Nat Rev Cancer. 9:153–166.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Baus F, Gire V, Fisher D, Piette J and
Dulić V: Permanent cell cycle exit in G2 phase after DNA damage in
normal human fibroblasts. EMBO J. 22:3992–4002. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Hsu YL, Kuo PL, Lin LT and Lin CC: Asiatic
acid, a triterpene, induces apoptosis and cell cycle arrest through
activation of extracellular signal-regulated kinase and p38
mitogen-activated protein kinase pathways in human breast cancer
cells. J Pharmacol Exp Ther. 313:333–344. 2005. View Article : Google Scholar
|
|
31.
|
Niculescu AB III, Chen X, Smeets M, Hengst
L, Prives C and Reed SI: Effects of p21(Cip/Waf1) at both the G1/S
and the G2/M cell cycle transition: pRb is a critical determinant
in blocking DNA replication and in preventing endoreduplication.
Mol Cell Biol. 18:629–643. 1998.PubMed/NCBI
|
|
32.
|
El-Deiry WS, Tokino T, Velculescu VE, Levy
DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and
Vogelstein B: WAF1, a potential mediator of p53 tumor suppression.
Cell. 75:817–825. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Gartel AL and Tyner AL: Transcriptional
regulation of the p21(WAF1/CIP1) gene. Exp Cell Res. 246:280–289.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Lee J and Kim SS: The function of p27 KIP1
during tumor development. Exp Mol Med. 41:765–771. 2009. View Article : Google Scholar : PubMed/NCBI
|
